Table 1 Basic characteristics of patients enrolled in this study.

From: A promising predictive biomarker combined EBV NDA with PNI for nasopharyngeal carcinoma in nonendemic area of China

Characteristics

N(%)

Characteristics

N(%)

Age(y)

50(43,60)

Pathology type

 

Gender

 

Non-keratinizing carcinoma

478(96.96)

 Male

346(70.2)

Keratinizing carcinoma

15(3.04)

 Female

147(29.8)

Alcohol

 

T stage*

 

Yes

150(30.43)

 T1

29(5.88)

No

343(69.57)

 T2

128(25.96)

Smoking

 

 T3

166(33.67)

Yes

210(42.60)

 T4

170(34.48)

No

283(57.40)

N stage*

 

Family history of cancer

 

 N0

12(2.44)

Yes

55(11.16)

 N1

74(15.01)

No

438(88.84)

 N2

291(59.02)

Family history of NPC

 

 N3

116(23.53)

Yes

17(3.45)

M stage*

 

No

476(96.55)

 M0

456(92.49)

PNI

 

 M1

37(7.51)

 ≤ 52.6

304(61.70)

Clinical stage*

 

 > 52.6

189(38.30)

 II

29(5.88)

EBV DNA(Copies/ml)

 

 III

200(40.57)

 ≤ 262.7

317(64.30)

 IVa

227(46.04)

 > 262.7

176(35.70)

 IVb

37(7.51)